MedPath

Evaluation of the Effectiveness and Safety of Diluted RADIESSE® in the Treatment of Décolleté Wrinkles

Not Applicable
Active, not recruiting
Conditions
Décolleté Wrinkles
Interventions
Device: Treatment with diluted Radiesse
Registration Number
NCT05163353
Lead Sponsor
Merz North America, Inc.
Brief Summary

Trial to confirm the effectiveness and demonstrate the safety of treatment with diluted Radiesse for correction of Décolleté Wrinkles.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
152
Inclusion Criteria
  • Female between ≥ 30 and ≤ 65 years old at the time of the screening.
  • Subjects seeking improvement of décolleté wrinkles.
Exclusion Criteria
  • Any previous surgery, including plastic surgery or permanent surgical implant in the treatment area.
  • Previous treatment with collagen fillers, calcium hydroxylapatite, and/or long-lasting hyaluronic acid (HA) fillers in the décolleté, or with other HA fillers in the décolleté.
  • Previous treatment with botulinum toxin, ablative or fractional laser, microdermabrasion, microneedling, chemical peels, and/or non-invasive skin tightening in the décolleté.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Delayed treatment with diluted RadiesseTreatment with diluted RadiesseDelayed injection of Décolleté Wrinkles with diluted Radiesse
Treatment with diluted RadiesseTreatment with diluted RadiesseInjection of Décolleté Wrinkles with diluted Radiesse
Primary Outcome Measures
NameTimeMethod
Percentage of Responders on Merz Aesthetic Scale (MAS) - at restWeek 24

Using the validated 5-point photonumeric MAS where: 0 = no wrinkles to 4= very severe wrinkles

Secondary Outcome Measures
NameTimeMethod
Percentage of Participants with Improvement on Subject Global Aesthetic Improvement Scale (sGAIS)Week 24

Using the 5-point GAIS where: +3 (Very much improved), + 2 (Much improved), + 1 (Improved), 0 (No change), - 1 (Worse), - 2 (Much worse),- 3 (Very much worse)

Number of Participants with TEAEs related to treatmentBaseline to week 84
Percentage of Responders on Merz Aesthetic Scale (MAS) - dynamicWeek 24

Using the validated 5-point photonumeric MAS where: 0 = no wrinkles to 4= very severe wrinkles

Percentage of Participants with Improvement on Investigator Global Aesthetic Improvement Scale (iGAIS)Week 24

Using the 5-point GAIS where: + 3 (Very much improved), + 2 (Much improved), + 1 (Improved), 0 (No change), - 1 (Worse), - 2 (Much worse),- 3 (Very much worse)

Trial Locations

Locations (9)

Clinical Testing of Beverly Hills, Merz Investigational Site #0010395

🇺🇸

Beverly Hills, California, United States

Facial Plastic Surgery, Merz Investigational Site #0010463

🇺🇸

Redondo Beach, California, United States

Private Practice, Merz Investigational Site #0010299

🇺🇸

Santa Monica, California, United States

Face Beautiful Inc, Merz Investigational Site #0010358

🇺🇸

Vista, California, United States

Skin Associates of South Florida, Merz Investigational Site #0010101

🇺🇸

Coral Gables, Florida, United States

The Graivier Center, Merz Investigational Site #0010464

🇺🇸

Alpharetta, Georgia, United States

Nashville Center for Laser and Facial Surgery, Merz Investigational Site #0010353

🇺🇸

Nashville, Tennessee, United States

Cosmetic Laser Dermatology, Merz Investigational Site #0010321

🇺🇸

San Diego, California, United States

Research Institute of the Southeast, LLC, Merz Investigational Site #0010420

🇺🇸

West Palm Beach, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath